US WorldMeds

Developing and commercializing therapies for rare and challenging medical conditions.

Founded 2001 · 350 employees · United States · Private

Funding:

Debt Financing · $235M · 2025

Subsidiaries:

Solstice Neurosciences, HEMA Biologics, USWM CT